Although some studies have reported that antidepressants are effective in treating IFN-α/RBV-associated depression during or after treatment of CHC [21]–[29], whether antidepressant prophylaxis is necessary in this population remains a subject for debate [26]–[36]. This evidence concerns the gene IFNA17 and depressive disorder.